Tumor necrosis factor α is a powerful apoptotic inducer in lymphoid leukemic cells expressing the P-170 glycoprotein

Walter Malorni(Istituto Superiore di Sanità), Ugo Testa(Istituto Superiore di Sanità), M. Lehnert(Merck & Co., Inc., Rahway, NJ, USA (United States)), Elena Tritarelli(Istituto Superiore di Sanità), Gabriella Rainaldi(Istituto Superiore di Sanità), Maurizio Cianfriglia(Istituto Superiore di Sanità), Roberto Rivabene, Gianfranco Donelli(Fondazione Santa Lucia), Cesare Peschele(Thomas Jefferson University)
International Journal of Cancer
July 17, 1996
10.1002/(sici)1097-0215(19960717)67:2<238::aid-ijc15>3.0.co;2-7
Cited by 21

Related Papers

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
|Cell Death and Differentiation|2008|3.3k
Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
|Clinical Cancer Research|2015|799
The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells
|Cell|1993|610
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.
|PubMed|1996|388
Unravelling the Complexity of T Cell Abnormalities in Common Variable Immunodeficiency
|The Journal of Immunology|2007|274